Skip to main content
CYAB
NASDAQ Technology

Director Flanagan James Francis Puts $109K into Cyabra Private Placement

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Software Stocks · Technology
Sentiment info
Positive
Importance info
8
Price
$0.334
Mkt Cap
$4.693M
52W Low
$0.306
52W High
$14.91
52W Position info
9.2% above low
Off High info
98% below high
Rel. Volume info
0.4× avg
Market data snapshot near publication time

CYAB is trading near its 52-week low of $0.306 (9.2% above the low) on light trading volume (0.4× avg).

Summary

Director Flanagan James Francis invested $109,193 in Cyabra's private placement, acquiring shares and warrants alongside the CEO. The insider buy underscores board confidence amid a going-concern warning and delisting risk.


Key Events · Ownership and Investor Activity · CYAB

  • Director Invests $109K in Private Placement

    Director Flanagan James Francis purchased 114,940 common shares at $0.435 and 229,880 warrants (114,940 Series A at $0.50, 114,940 Series B at $0.45) for a total of $109,193 in Cyabra's $6M private placement.

  • Insider Commitment Amid Distress

    The purchase follows CEO Dan Brahmy's $74,305 investment in the same placement, with both insiders backing the company despite a going-concern warning and Nasdaq delisting notice.

  • Warrant Terms and Potential Dilution

    Series A warrants are exercisable at $0.50 for five years; Series B warrants at $0.45 for one year, both pending stockholder approval. If exercised, they would add 229,880 shares, representing significant potential dilution for a micro-cap company.

  • Post-Transaction Ownership

    Flanagan now directly holds 344,820 shares (including 114,940 from the grant and 229,880 from warrant exercise potential), aligning his interests with shareholders.


Analysis · CYAB · Technology

Director Flanagan James Francis has purchased $109,193 in common stock and warrants in Cyabra's recent $6M private placement, joining CEO Dan Brahmy in backing the company. The investment includes 114,940 shares at $0.435 and warrants for 229,880 shares at $0.45–$0.50. This insider commitment arrives as Cyabra confronts a going-concern warning and a Nasdaq delisting threat, signaling board-level confidence in the company's survival despite severe financial distress.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CYAB was trading at $0.33 on NASDAQ in the Technology sector, with a market capitalization of approximately $4.7M. The 52-week trading range was $0.31 to $14.91. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CYAB - Latest Insights

CYAB
Nov 18, 2026, 4:30 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.082
Real-time Price: $0.0559 info
Change: Reverse Stock Split info
Market Cap: $2.408M info
CYAB
Nov 16, 2026, 5:29 PM EST
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.1222
Real-time Price: $0.0559 info
Change: Reverse Stock Split info
Market Cap: $2.408M info
CYAB
Nov 16, 2026, 9:26 AM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.1556
Real-time Price: $0.0559 info
Change: Reverse Stock Split info
Market Cap: $2.408M info
CYAB
Nov 16, 2026, 9:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $0.1144
Real-time Price: $0.0559 info
Change: Reverse Stock Split info
Market Cap: $2.408M info
CYAB
Nov 10, 2026, 5:21 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.0847
Real-time Price: $0.0559 info
Change: Reverse Stock Split info
Market Cap: $2.408M info